An interventional study of Hybrid Ceramics CAD/CAM overlays and Lithium disilicate CAD/CAM overlays in Endodontically Treated Molar, sponsored by Cairo University. Not yet recruiting. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This randomized clinical trial aims to compare the clinical performance, wear behavior and relative occlusal force distribution of hybrid ceramic and lithium disilicate CAD/CAM overlays in endodontically treated molars over a 24-month follow up period using Modified USPHS criteria, Geomagic control software and digital occlusal analyzer respectively
Cairo University is the lead sponsor of 4,956 studies on the registry; 1,466 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Endodontically treated molars will receive lithium disilicate CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.
Other: Lithium disilicate CAD/CAM overlays
Endodontically treated molars will receive Hybrid ceramics CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.
Other: Hybrid Ceramics CAD/CAM overlays
Endodontically treated molars will be prepared to receive hybrid ceramics overlays following the concept of morphology driven preparation. This includes cuspal reduction for the buccal and lingual walls, removal of all undermined enamel, slight flaring of the cavity walls to 6-10-degree divergence. After proper cavity preparation, immediate dentin sealing and cavity optimization will be done followed by scanning, milling and finally cementation of the overlay restoration.
Endodontically treated molars will be prepared to receive lithium disilicate CAD/CAM overlays. Preparation includes cuspal reduction of the buccal and lingual walls 1.5 to 2 mm, removal of all undermined enamel and slight flaring of the cavity walls to 6-10-degree divergence. Following cavity preparation, immediate dentin sealing and cavity optimization followed by scanning and milling of the restoration. Cementation will then follow based on manufacturer instructions using resin cement. Surface treatment including etching of the fitting surface using 9.5% hydrofluoric acid for 20 seconds followed by cleaning for 60 seconds using 37% phosphoric acid gel followed by silane application.
Wear Assessment
The volumetric loss of the overlays will be measured by the software Geomagic Control Software
Time frame: baseline, 12 and 24 months
Clinical performance (Marginal Adaptation)
Marginal adaptation will be measured by two assessors following Modified USPHS criteria
Time frame: baseline, 6, 12, 18 and 24 months
Relative Occlusal load distribution
relative occlusal load distribution will be measured by digital occlusal analysis system OccluSense
Time frame: Immediately, 6 and 12 months
No study locations are listed for this record.
Plan to share: No — The dataset contains coded but potentially re-identifiable clinical and patient information. Per the study confidentiality plan, data access is restricted to the principal investigator and study supervisors only with records stored securely under password-protected, limited access systems. No plan for sharing individual participant data with external researchers is currently in place.
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.